As of 2025-07-03, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 92.73 USD. This relative valuation is based on P/E multiples. With the latest stock price at 53.84 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 72.2%.
The range of the Relative Valuation is 64.36 - 131.25 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 24.3x | 20.3x |
| Forward P/E multiples | 17.5x - 28.7x | 23.1x |
| Fair Price | 64.36 - 131.25 | 92.73 |
| Upside | 19.5% - 143.8% | 72.2% |
| Date | P/E |
| 2025-07-01 | 13.43 |
| 2025-06-30 | 13.21 |
| 2025-06-27 | 13.25 |
| 2025-06-26 | 13.34 |
| 2025-06-25 | 13.28 |
| 2025-06-24 | 13.68 |
| 2025-06-23 | 13.40 |
| 2025-06-20 | 13.41 |
| 2025-06-18 | 13.49 |
| 2025-06-17 | 13.48 |
| 2025-06-16 | 13.69 |
| 2025-06-13 | 13.70 |
| 2025-06-12 | 13.85 |
| 2025-06-11 | 13.67 |
| 2025-06-10 | 13.65 |
| 2025-06-09 | 13.81 |
| 2025-06-06 | 13.77 |
| 2025-06-05 | 13.59 |
| 2025-06-04 | 13.67 |
| 2025-06-03 | 13.53 |
| 2025-06-02 | 14.13 |
| 2025-05-30 | 14.23 |
| 2025-05-29 | 13.89 |
| 2025-05-28 | 13.82 |
| 2025-05-27 | 13.82 |
| 2025-05-23 | 13.85 |
| 2025-05-22 | 13.65 |
| 2025-05-21 | 13.69 |
| 2025-05-20 | 13.57 |
| 2025-05-19 | 13.53 |
| 2025-05-16 | 13.21 |
| 2025-05-15 | 12.43 |
| 2025-05-14 | 12.16 |
| 2025-05-13 | 12.75 |
| 2025-05-12 | 16.90 |
| 2025-05-09 | 16.72 |
| 2025-05-08 | 17.19 |
| 2025-05-07 | 17.81 |
| 2025-05-06 | 15.07 |
| 2025-05-05 | 15.39 |
| 2025-05-02 | 15.53 |
| 2025-05-01 | 15.24 |
| 2025-04-30 | 15.59 |
| 2025-04-29 | 15.44 |
| 2025-04-28 | 15.38 |
| 2025-04-25 | 15.36 |
| 2025-04-24 | 15.04 |
| 2025-04-23 | 14.83 |
| 2025-04-22 | 14.78 |
| 2025-04-21 | 14.54 |